(0.07%) 5 473.11 points
(0.10%) 39 150 points
(0.38%) 17 785 points
(0.15%) $80.95
(-3.66%) $2.66
(-0.77%) $2 312.90
(0.25%) $28.94
(3.64%) $1 022.30
(0.29%) $0.936
(0.69%) $10.68
(0.43%) $0.792
(-0.28%) $87.24
Live Chart Being Loaded With Signals
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders...
Stats | |
---|---|
今日成交量 | 231 126 |
平均成交量 | 132 918 |
市值 | 6.50M |
EPS | $-0.320 ( Q1 | 2023-05-18 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0980 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00400 (4.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-01-03 | Khanna Ashish | Buy | 375 000 | Stock Option (Right to Buy) |
2023-01-03 | Riedel Norbert G | Buy | 420 000 | Stock Option (Right to Buy) |
2023-01-03 | Kidd Andrew | Buy | 700 000 | Stock Option (Right to Buy) |
2022-05-26 | Koppel Adam | Buy | 40 000 | Stock Option (Right to Buy) |
2022-05-26 | Koppel Adam | Buy | 40 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 97 transactions |
Buy: 16 590 862 | Sell: 1 518 818 |
音量 相关性
Aptinyx Inc 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Aptinyx Inc 相关性 - 货币/商品
Aptinyx Inc 财务报表
Annual | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-0.950 |
FY | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $-0.950 |
FY | 2021 |
营收: | $1.00M |
毛利润: | $0.00 (0.00 %) |
EPS: | $0 |
FY | 2020 |
营收: | $1.56M |
毛利润: | $1 564.00 (0.10 %) |
EPS: | $-1.020 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Aptinyx Inc
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II/b clinical trial for treating fibromyalgia. It is also developing NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase II/b clinical trial to treat post-traumatic stress disorder; and NYX-458, an NMDAr modulator, which is in Phase II clinical study for the treatment of Parkinson's disease cognitive impairment. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。